Top Markets
#1 Seeker Seeker +15.40%
#2 Official Trump Official Trump +12.94%
#3 DeFi Kingdoms DeFi Kingdoms +10.56%
#4 Ethena Staked ENA Ethena Staked ENA +9.25%
#5 EXOD EXOD +9.04%
#6 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +8.10%
#7 peaq peaq +7.28%
#8 TDCCP TDCCP +5.86%
#9 Melania Meme Melania Meme +5.55%
#10 Stacks Stacks +5.26%
Coin of the day
Seeker Seeker
설정
언어
한국어
통화
USD
테마
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.

Taysha Gene Therapies, Inc.

TSHA
주식 순위 #6652
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and... Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
주가
$6.02
마지막 동기화: 2026-08-27
시가총액
$1.93B
변동 (1일)
0.00%
변동 (1년)
112.72%
국가
US
거래 Taysha Gene Therapies, Inc. (TSHA)

카테고리

Healthcare
Taysha Gene Therapies, Inc. (TSHA)의 수익
2026 기준 수익 TTM: 0
Taysha Gene Therapies, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Taysha Gene Therapies, Inc.의 수익 기록 (2026 ~ 2026)
연말 수익
연도 수익 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH